Pharvaris N.V. (PHVS) stock
PHVSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$31.55−0.73 (-2.26%)
Close on Nov 18, 2026Market cap $2.06BP/E –Yield –
Pharvaris shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Pharvaris's shares outstanding was 68M at Jun 30, 2026. For fiscal 2025 it was 59M, up 9.5% from the year before. The highest annual figure on record is 59M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 59M | +9.5% |
| FY2024 | Dec 31, 2024 | 54M | +40.7% |
| FY2023 | Dec 31, 2023 | 38M | +14.3% |
| FY2022 | Dec 31, 2022 | 34M | +10.4% |
| FY2021 | Dec 31, 2021 | 30M | +527.0% |
| FY2020 | Dec 31, 2020 | 5M | 0.0% |
| FY2019 | Dec 31, 2019 | 5M | 0.0% |
| FY2018 | Dec 31, 2018 | 5M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 68M | +102.7% |
| Q2 FY2025 | Jun 30, 2025 | 55M | +65.1% |
| Q2 FY2024 | Jun 30, 2024 | 54M | – |
| Q2 FY2023 | Jun 30, 2023 | 35M | – |
| Q2 FY2022 | Jun 30, 2022 | 34M | – |
| Q2 FY2021 | Jun 30, 2021 | 33M | – |
See a number that looks wrong?